MLTX INVESTOR ALERT: MoonLake Immunotherapeutics Securities Fraud Investigation Initiated – Preserve Your Rights by Contacting BFA Law
NEW YORK CITY, NY / ACCESS Newswire / October 2, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into MoonLake Immunotherapeutics (NASDAQ:MLTX) for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/moonlake-immunotherapeutics. Why Is MoonLake being […]